Assessment of Pharmaceuticals, Personal Care Products, and Hormones in Wastewater Treatment Plants Receiving Inflows from Health Facilities in North West Province, South Africa

Table 3

Mass spectrometry parameters for pharmaceutical and hormone analysis (quantitative ion marked in bold; confirmation ion).

Compound	Precursor m/z	Product m/z	Cone voltage (V)	Collision energy (eV)
Negative mode
Ketoprofen (KET)	253.3	209.29	15	8
Ibuprofen (IBU)	205.4	161.3	17	9
Bezafibrate (BEZ)	360.2	274; 153.95	13	16
Triclosan (TCS)	286.8	35; 141.8	22	11
Triclocarban (TCC)	313.1	159.9; 126.05	12	13
Chloramphenicol	321.1	152; 257.05	16	19
Estrone (E1)	269.2	145.10; 143.05	14	46
17β-estradiol (β-E2)	271.2	145.10; 183.10	14	47
Estriol (E3)	287.2	143.05; 171.15	15	43
17α-ethinylestradiol (EE2)	295.3	145.05; 159.05	11	47
Positive mode
Tetracycline (TCN)	444.9	410; 154.1	-13	-21
Nalidixic acid (NAL)	232.9	215.05; 187	-18	-16
Atenolol (ATE)	267	145; 190	-14	-29
Acetaminophen (ACE)	151.9	110.1; 65.15	-11	-24
Ofloxacin (OFL)	362	318.1; 261.05	-14	-22
Norfloxacin (NOR)	320	302.05; 231.05	-16	-22
Ciprofloxacin (CIP)	332	314.1; 231	-13	-23
Diclofenac sodium salt (DIC)	318	23.2; 58.75	-12	-15